360 Stem Cell & Regenerative Medicine Newsletter- December 11, 2014

 weSRCH's Best of the Internet Award
  11th-Dec-2014
 1566

360 Stem Cell & Regenerative Medicine Newsletter - Dec 11, 2014

Featured Video : Genetics Policy Institute (GPI) and Regenerative Medicine Foundation (RMF) to merge

The Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and the Regenerative Medicine Foundation (RMF) have agreed to merge in order to leverage their resources in the advancement of stem cell research, regenerative medicine and other advanced technologies targeting cures. They made a joint announcement at the opening session of the 10th Annual World Stem Cell Summit (#wscs14) in San Antonio, Texas. The merged organization is to be called the Regenerative Medicine Foundation. The Genetics Policy Institute will become the think tank and policy arm of the merged organization. Bernard Siegel, executive director of GPI, will serve as executive director of the new Regenerative Medicine Foundation. Dr. Anthony Atala, founder and chairman of the board of RMF, will sit on the board of directors of the merged organization. - See more here.
TerumoBCT
San Antonio Business Journal: San Antonio could see significant gains from World Stem Cell Summit
“The three-day World Stem Cell Summit may have concluded on Friday, Dec. 5, but its impact on San Antonio could be felt for decades, said StemBioSys co-founder Steven Davis, who was also one of the bioscience industry leaders responsible for bringing the global conference to the city.” Note: click here to a link for a related story about the impact of the Summit from the San Antonio Business Journal headlined, “San Antonio’s First World Stem Cell Summit a Big Success, conference founder says.”
Time: This new kind of stem cell may revolutionize how we treat diseases- Scientists have created a new type of stem cell that could speed treatments for diseases and make them safer
Could this be the stem cell story of the year? “Scientists led by Dr. Andras Nagy at Mount Sinai Hospital Lunenfeld-Tannenbaum Research Institute in Toronto report an exciting new advance that could push stem cells even closer to the clinic. In a series of papers in the journals Nature and Nature Communications, the group describes a new class of stem cell, which they called F class, that they generated in the lab. The F class cells, says Nagy, have a few advantages over the Yamanaka-generated induced pluripotent stem cells, or iPS cells. While the iPS cells are created by using viruses to introduce four genes that reprogram the cells, Nagy’s team relied on a technique they developed several years ago using transposons—small pieces of DNA that can insert themselves into different parts of a genome. Unlike viruses, these transposons can be popped out of the genome if they’re no longer needed, and they don’t carry the potential risk of viral infection.”
Rainbow Scientific
MIT Technology Review: The NFL has a problem with stem cell treatments- Professional athletes are getting injections of stem cells to speed up recovery from injury. Critics call it a high-tech placebo
Editor and journalist Antonio Regalado neatly summarizes the controversy surrounding elite NFL stars being treated with non-compliant stem cell treatments. “Although the treatments have become a multimillion-dollar industry, some doctors say there’s only thin medical evidence they actually speed healing. In a report issued last week, public policy researchers at Rice University criticized the National Football League’s role in promoting ‘unproven’ treatments to the public. Some players, including Peyton Manning of the Denver Broncos and Sidney Rice, who’s now retired but won a Super Bowl with the Seattle Seahawks last year, have reportedly gone overseas for stem cell treatments and others have acted as spokespeople for U.S. clinics offering them. The Rice researchers, Kirstin Matthews and Maude Cuchiara, say the NFL should create an independent panel and fund research on whether stem cell treatments actually work, similar to what it did after facing questions around concussions and brain injury.”. Click here to read "U.S. National Football League Athletes Seeking Unproven Stem Cell Treatments" published December 2014 by the World Stem Cell Report.
Conquer Paralysis Now launches challenge to find a cure in next decade- Nearly $20 million in grants and awards available including $10 million grand prize
Conquer Paralysis Now (CPN) has launched a groundbreaking competition to cure paralysis in the next 10 years. The announcement was made by Ida Cahill, president and CEO of CPN, at the World Stem Cell Summit in San Antonio, Texas. The CPN Challenge Program plans to award nearly $20 million dollars in grants and prizes, including a tentative $3 million in business and entrepreneurial awards to be announced later, over the next 10 years. The first team that can reach unprecedented improvement in every day functions of people living with chronic SCI will win the $10 million grand prize.
StemBioSys
Harvard Gazette: A pill to shed fat? Harvard stem cell researchers say they finally can turn ‘bad’ fat into ‘good’
Promising news in time for the holidays. “Harvard Stem Cell Institute (HSCI) researchers have taken what they describe as ‘the first step toward a pill that can replace the treadmill’ for the control of obesity, though that shift, of course, would not provide all of the many benefits of exercise.”
Irvine Scientific
Stem Cells from adult nose tissue used to cure Parkinson’s Disease in rats
Scientists have for the first time used adult human stem cells to “cure” rats with Parkinson’s disease, a neurodegenerative illness that currently has no cure. The study, published in the current issue of STEM CELLS Translational Medicine, the official journal partner of the Regenerative Medicine Foundation. Note: see featured 360 video (above) relating to merger of Regenerative Medicine Foundation and Genetics Policy Institute, the publisher of this online publication, the 360 Stem Cells and Regenerative Medicine Newsletter.
European drug target review
The Seattle Times: Microsoft mogul Paul Allen gives $100 million for new Seattle institute to unravel cells
“Paul Allen announced he is donating $100 million over five years for the Allen Institute for Cell Science in Seattle. That’s the same initial amount he committed to the Allen Institute for Brain Science in 2003. Since then, Allen has invested $400 million more, increasing the staff to 350 people and making the brain institute his single largest philanthropic effort. The cell institute could follow a similar trajectory if it is able to make progress toward unraveling the inner workings of human cell.”
NBC News: Costly, unproven stem cell therapy for neurological disorders questioned
This is an investigative piece by NBC News presents all sides of the controversy.
Frost & Sullivan
Future Science Group launches RegMedNet at the 2014 World Stem Cell Summit
Future Science Group (FSG) unveiled RegMedNet - an interactive online resource for the regenerative medicine community. Users of RegMedNet will be able to view featured articles, interviews, webinars, industry news from FSG and select partners and much more. The site features selected content from the peer-reviewed journal Regenerative Medicine and highlights key content from other related journals. Site content and functionality is entirely free to all site registrants.”
San Antonio Business Journal: Biotech firm Aperion Biologics ready to launch first device in Europe
“Aperion Biologics, one of several San Antonio-based bioscience firms that had an opportunity to pitch to potential investors on Thursday during the World Stem Cell Summit's inaugural RegMed Capital Conference, is only weeks away from rolling out its initial product. Aperion also launched a new $10 million funding round to support its growth plans. RegMed refers to regenerative medicine.”
SwRI
Cellular Biomedicine Group releases positive 48-week data from Phase I/IIa Clinical Trial for ReJoin(TM) treatment of knee osteoarthritis (KOA)
This announcement was made at the RegMed Capital Conference at WSCS14 in San Antonio.
NeoStem's subsidiary, Progenitor Cell Therapy, earns AABB re-Accreditation for Its Allendale, NJ manufacturing facility

360 Newsletter Editor


Bernard Siegel
Executive Director
Genetics Policy Institute




Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter
Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018